Netherlands Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

The Netherlands infection control market is projected to grow at a compound annual growth rate of 7.78% over the forecast period to attain a market size of US$144.788 million in 2027, from US$85.694 million in 2020. The presence of the varied type of hospitals in the Netherlands, which include the major three types of hospitals, namely academic hospitals, general hospitals, and teaching hospitals, are offering offers heaps of opportunities for the market to increase in the forecast period owing to avoid the avoidance of hospital-associated infections in the forecast period. The Prevalence of single or multiple diseases affects many men and women. As a result, they need particular treatments at various illness stages, which will further drive demand in the market over the projection period. The presence of the elderly population in the country is projected to drive the market demand during the forecast period. Furthermore, the establishment of advanced manufacturing operations by various multinational industries is further poised to augment the market demand in the forecast period.

Over the next five years, it is anticipated that the presence of a single particular or many morbidities will drive market expansion.

The presence of single specific and multiple diseases in the elderly population in the Netherlands is affecting many men and women. This provides an opportunity for the market to thrive in the forecast period as the global population ages. Along with an ageing population in this country, the population will require treatment at different disease stages, propelling the market growth in the forecast period. Common diseases include osteoarthritis, diabetes, and coronary heart disease. To address these issues in the country, several cost-effective treatments and specialized treatments are available to improve the patient's quality of life. This has further led to the decline in declining of disability of the senior population on a large scale. Also, special infection control measures must be taken while dealing with the elderly population, as these people are highly susceptible to infections due to their weak immune systems.

Furthermore, the Prevalence of chronic diseases is expected to continue to increase with the growing senior population in the country. Efforts are being taken for early disease detection and an improvement in the treatment of diseases. According to the National Institute for Public Health and the Environment, the Netherlands, the number of people suffering from diabetes mellitus is estimated to rise from 0.8 million in 2011 to 1.2 million by the end of 2030. As a result, it is predicted that by 2030, there will be 7 million people who suffer from chronic diseases, up from 5.3 million in 2011.

The setting up of advanced manufacturing operations by multinationals will augment the market demand in the forecast period.

The Netherlands holds a strong position as a manufacturing location in the European region for many companies from abroad. As a result, the nation is home to the manufacturing operations of major global corporations. The major ones include agriculture, life sciences, chemicals, and information technology. This is further encouraged by the supportive Holland's corporate tax structure, a highly talented workforce with fluency in multiple languages, and exceptional engineering skills. This is aided further by Holland's supportive corporate tax structure and a highly talented workforce with fluency in multiple languages and exceptional engineering skills.

Key Developments:

• Apr 2020: AED Group has launched a new range of products featuring UVC technology in the fight against COVID-19. The company supplies professional audiovisual material to more than 60,000 events around the world every year. The new range of products is being launched under AED group's Luxibel brand. The fixtures are manufactured in Europe and use high-quality Philips UV components.

COVID-19 SCENARIO

The pandemic of COVID-19 had a huge impact on the Netherland infection control market. The pandemic has caused havoc on healthcare systems around the world, with hospitals becoming overcrowded as the number of patients climbs. Temporary hospitals are being built to handle the influx of cases. The spread of COVID-19 has caused a boom in demand for cleaning and disinfection products because of the heightened awareness about cleanliness, health, and safety. However, it is anticipated that the infection control business will suffer severely in the post-COVID situation.

Netherlands Infection Control Market Scope:

Segmentation:

• By Product
  • Disinfectant
  • Sterilization
    • Low temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical

3M

Medtronic Trading NL BV The Netherlands

STERIS plc

B. Braun Melsungen AG

Schülke & Mayr GmbH